Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to Tumors – MedCity News
Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this…
Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this…
A venture-backed healthcare startup wants to fix how employers pay for GLP-1s — without touching insurance. Andel launched its direct-to-employer…
The next frontier for cell therapy is shaping up to be in vivo treatments for autoimmune disease, and Eli Lilly…
Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques,…
AI healthcare concept stocks in the Hong Kong stock market collectively surged, $FANGZHOU JIANKE (06086.HK)$ with some rising over 36%,…
Michelle Carnahan spent four years as the president of VC-backed healthcare startup Thirty Madison, and before that, had a two-decade-long…
Eli Lilly (NYSE:LLY) just pre-announced a $1.57 billion pre-tax charge related to acquired in-process R&D, which is expected to weigh…